Big picture immunology: Body size shapes immune strategies across species
Cynthia Downs, PhD
Department of Environmental Biology, SUNY ESF
Syracuse University, Biology Seminar Series
This Week in Research
Home »March 18 - 24, 2024
FDA announces funding opportunity for digital health technologies
Advanced Neural Stem Cell Therapies for CNS Traumatic and Degenerative Diseases
Mohamad Khazaei, PhD
Scientific Associate, Krembil Brain Institute, University of Toronto / University Health Network
Departments of Neurosurgery and Neuroscience & Physiology, SUNY Upstate Medical University
Department of Neurosurgery Faculty Candidate
Fundamentals of Working with the Media
Virgie Townsend, JD
Director of Public Relations, Strategic Communications
CNYBAC Concept to Commercialization Virtual Series
This interactive presentation will cover the fundamentals of working with the news media, including how to prepare for phone, virtual, and in-person interviews with TV, print/online, and radio/podcast reporters. Speaker will discuss and review: An overview of today’s 24/7 media, including the role that web and social media play; Understanding of news reporters and editors, and how they approach their jobs; Key attributes of an effective organization spokesperson; Best practices and specific “dos and don’ts” for media interviews, including how to handle in-person versus virtual interviews and; Key phrases that help spokespersons stay on track with a company’s key messages. Click here to register.
Student Research Day
This annual event highlights student research from all four colleges at Upstate: Graduate Studies, Health Professions, Medicine and Nursing. The Student Research Day has become a tradition at Upstate and has developed into a well-respected event that includes a keynote presentation, seven student talks, and an early evening poster session and reception.
SUNY TAF Accepting Proposals
We are pleased to announce that the application period for the SUNY Technology Accelerator Fund Class of 2024 is now OPEN!
The SUNY Technology Accelerator Fund (TAF) provides critical investments to advance SUNY innovation from the lab to the marketplace. TAF investments are highly competitive and support technology development milestones, such as feasibility studies, prototyping, and clinical and field testing, to demonstrate that an innovation has commercial potential.
Faculty, staff, and students from all disciplines and campuses are encouraged to submit proposals for TAF Class of 2024 funding.
Please be advised that all proposals require the review and participation of your campus administration prior to submission. To be certain that you adhere to any local proposal submission deadlines, we urge you to immediately contact your technology transfer office and/or office of sponsored programs if you are interested in participating in the TAF Class of 2024 investment round.
The deadline for submitting proposals is March 20, 2024. For more information, please review the TAF Class of 2024 Application and Administrative Guidelines or contact Jennifer Rudes at rudesj@upstate.edu.
Phosphorylation of the mitochondrial chaperone TRAP1 regulates cancer cell survival
Mark Woodford, PhD
Assistant Professor, Lab, Department of Urology
Grand Rounds - Department of Urology
Mitochondrial fission defects drive disruptive neurogenesis in the rare disease EMPF1
Vivian Gama, Ph.D.
Associate Professor Department of Cell and Developmental Biology Vanderbilt University Nashville, Tennessee
Department of Pharmacology
The U.S. Food and Drug Administration announced a funding opportunity, open March 18-May 20, 2024, for selected applicants to explore the role of digital health technologies (DHTs) (e.g., actigraphy, photography, environmental sensors) in the evaluation of new drugs.
Projects may involve engagement with researchers from academia, the biopharmaceutical industry, patient groups, and other stakeholders. The objectives of these projects are to advance DHTs for clinical drug development, expand the ability to capture early manifestations of chronic diseases, determine outcomes in populations with unmet medical needs and enhance convenience for trial participants by allowing for remote data acquisition in clinical investigations.
The scope includes, but is not limited to, projects that focus on:
For more information, please see RFA-FD-24-037.